Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cross Country Healthcare has the GF Score of 53, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Cross Country Healthcare
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Cross Country Healthcare (FRA:XXY) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Cross Country Healthcare GF Score Related Terms
FRA:XXY vs SRTA, CYH, AUNA: GF Score Comparison
For the Medical Care Facilities subindustry, Cross Country Healthcare's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cross Country Healthcare GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cross Country Healthcare's GF Score distribution charts can be found below:
* The bar in red indicates where Cross Country Healthcare's GF Score falls into.
Cross Country Healthcare (FRA:XXY) has a GF Score of 53 as of Jul. 17, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cross Country Healthcare and its competitors. This is 28% below median its historical median of 74.00. Over the past decade, Cross Country Healthcare's GF Score has ranged from 27.00 to 85.00.
Is Cross Country Healthcare's GF Score too high?
Cross Country Healthcare's current GF Score of 53 is 28% below median its 10-year median of 74.00. Over the past 10 years, this metric has ranged from a low of 27.00 to a high of 85.00. Overall, Cross Country Healthcare has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Cross Country Healthcare's GF Score compare to SRTA and CYH?
Cross Country Healthcare's GF Score of 53 can be compared against companies in the Healthcare Providers & Services industry. Historically, Cross Country Healthcare's own GF Score has ranged from 27.00 to 85.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cross Country Healthcare and its competitors. Cross Country Healthcare's current GF Score is 53, which is 28% below median its own 10-year median of 74.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cross Country Healthcare stock overvalued right now?
Cross Country Healthcare (FRA:XXY) has a current GF Score of 53. The stock's GF Value™ is €9.07, compared to a current price of €11.50 — trading 26.8% above its estimated fair value. The current GF Score is 53, which is 28% below median its 10-year median of 74.00. Cross Country Healthcare's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Cross Country Healthcare (FRA:XXY), the current GF Score is 53 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cross Country Healthcare (FRA:XXY) Overvalued in 2026?
Based on GuruFocus' analysis, Cross Country Healthcare stock appears to be overvalued.
The current stock price of €11.50 is trading 26.8% above its estimated GF Value™ of €9.07.
Key valuation signals for FRA:XXY:
GF Score: 53 (28% below median its 10-year median of 74.00)
GF Value™: €9.07 vs. price of €11.50 (26.8% above fair value)
No single metric tells the full story. See the FRA:XXY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
53GF Score
Get the complete analysis for FRA:XXY
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XXY has been successfully added to your 
